The aim of this review is to draw attention to a preventable childhood condition, detailing the clinical presentation, diagnostic pathway and management.

This paper provides an update on the maintenance or discontinuation of antidepressant medication for adults.

This paper offers general practitioners tips and resources to for the effective care of patients diagnosed with borderline personality disorder.

This paper considers common mechanisms underpinning chronic conditions and how these mechanisms might be targeted therapeutically in primary care.

This paper aims to equip GPs with evidence-based strategies to prevent and mitigate heat‑related illnesses.

This article reviews the evidence on disaster health effects from an all-hazards perspective and highlight GPs’ essential role in disaster healthcare.

This paper describes the challenges faced by children and young people in the face of the unprecedented impact of climate‑related events or anxiety about planetary health.

This article provides a concise introduction to disaster planning for those who are new to Australian general practice or to general practice ownership.

The article discusses the problem that extreme heat poses for mental health and to provide examples of how these problems can be anticipated and mitigated.

A review of the pathophysiology, diagnosis and multimodal approach to the management of chronic rhinosinusitis.

This paper discusses the importance of oral cancer awareness in clinical practice

This article discusses general practice’s role in mitigating complications from acute otitis externa.

This paper describes a clinical approach to chronic respiratory disorders for clinicians working with Aboriginal and Torres Strait Islander people, particularly in the remote Australian context.

This article aims to provide the general practitioner with a practical guide and an up-to-date evidence-based review on how to manage the head and neck cancer survivor.

This article aims to provide evidence-based information to GPs, aiding the decision to initiate sodium–glucose cotransporter 2 (SGLT2) inhibitors for chronic kidney disease patients.